25岁女子查出肝癌!这一习惯成“罪魁祸首”

2021-01-23 39健康网 39健康网

小芬(化名)今年25岁,家住宝安,在一家IT企业上班。8月她到医院体检时,被检查出肝右前叶有肿块,复查被初步确诊为肝癌和肝硬化。据了解,小芬10年前患上乙肝。医生表示,熬夜加上不健康的生活方式,都是慢

小芬(化名)今年25岁,家住宝安,在一家IT企业上班。8月她到医院体检时,被检查出肝右前叶有肿块,复查被初步确诊为肝癌和肝硬化。据了解,小芬10年前患上乙肝。医生表示,熬夜加上不健康的生活方式,都是慢性乙肝发展为肝癌的危险因素!

事实上,像小芬这样把慢性乙肝硬生生拖成肝癌的不在少数。在中国,肝癌发病率和死亡率超过全球一半,其中乙肝病毒是诱发肝癌的最大隐患,80%以上肝癌都是乙肝转化而来的。

那有没有什么症状来提示肝癌?

早起症状非常不明显!健康的肝脏大约只需四分之一就能满足人体正常工作的需求,而在肝癌早期,肝脏功能往往是足够用的,人体很难有明显异常。而很多肝癌患者直到肿瘤大得撑起肚皮,才发现已经是晚期了。

有这些特点的人易患肝癌!

虽然肝癌的症状不明显,但是有这些特点的人就要小心患上肝癌了:

1、得过乙肝

在我国,约有 90% 的肝癌患者感染过乙肝病毒。因此感染过肝炎病毒的人,要多注意了。

2、有肝硬化

肝硬化的下一步往往就会发展为肝癌了

3、家族中有肝癌患者

肝癌有家族聚集现象,就比如患有乙肝的母亲,生孩子的过程中把乙肝病毒也传递给了下一代。不过也别太担心,母亲是乙肝病毒携带者,只要给孩子打乙肝疫苗及乙肝免疫球蛋白,也可以很好得到控制。

4、嗜酒

各种酒类当中的酒精在进入人体后都要经过肝脏进行分解和代谢,但是酒是人体干细胞的杀手,酒精的毒性会阻碍干 细胞分解脂肪酸,同时代谢也会发生异常,引起脂肪肝。

建议这几种人群,每6个月做一次腹部B超检查和血清甲胎蛋白检查。年龄大于40岁的人群也属于肝癌的高发年龄段,也需要进行每年一次的体检,如果有异常在进行进一步的检查。

该怎么预防肝癌?

1、 戒掉最伤肝的习惯:酗酒

小酒怡情,多饮伤肝。戒烟酒、均衡饮食、坚持锻炼,这三条是每个癌症预防的首要条件。

2、避免食用霉变的食物

霉变食物含有大量黄曲霉素,如果我们长时间摄入这种物质,就会导致慢性中毒、生长障碍,从而引起病变,纤维组织增生,诱发肝癌。

3、保持心情愉悦

中医的角度上来说,人的焦虑、烦躁、生气等负面情绪都会对肝造成伤害,生气伤肝,平时要多注意情绪控制。

4、避免长期熬夜

如果总是晚睡,对肝脏的伤害也是很大的,不是因为网上所说的肝脏需要在晚上修复,而是长期睡眠不足,会对植物神经系统和内分泌系统造成不良影响,影响肝脏健康。

5、杜绝盲目吃药

很多人,在生病了之后,第一时间,不是去医院,而是选择自己去药店自行购药,其实这种做法是很不正确的,因为药品主要在肝脏代谢分解,如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。所以,生活中因为某些问题需要服药,最好是先咨询医生,如果无可避免要吃一些伤肝药,记得同时做好保肝措施。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-09-14 ms3000000161626604

    如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-25 1486adbfm03暂无昵称

    好文章,学医的哪有不熬夜

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 1211c54em14(暂无昵称)

    现在几点算是熬夜

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 留走人康

    肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 ms5000000553117836

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 123adbc4m07暂无昵称

    好 不错

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1050141, encodeId=89ea1050141a3, content=如果用错药物,会直接刺激肝脏,损伤肝细胞,诱发严重肝损伤、肝衰竭、肝癌。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=ms3000000161626604, createdTime=Tue Sep 14 06:55:59 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919685, encodeId=f1259196854d, content=好文章,学医的哪有不熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e3f5293425, createdName=1486adbfm03暂无昵称, createdTime=Mon Jan 25 14:03:07 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919321, encodeId=033f9193216a, content=现在几点算是熬夜, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Sat Jan 23 23:56:09 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040344, encodeId=c3ac104034439, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sat Jan 23 23:07:42 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919301, encodeId=64569193018d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a675455227, createdName=ms5000000553117836, createdTime=Sat Jan 23 21:43:34 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919284, encodeId=0578919284b3, content=好 不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210123/7ab6e36a322645b3a23a2e72f8cdb5d6/5df418f97bc04b5ca1d4c900d9ab4980.jpg, createdBy=a5cc2428007, createdName=123adbc4m07暂无昵称, createdTime=Sat Jan 23 20:53:53 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919296, encodeId=af409192969d, content=学习了,习惯很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f10b5455214, createdName=ms9000001760161937, createdTime=Sat Jan 23 21:21:02 CST 2021, time=2021-01-23, status=1, ipAttribution=)]
    2021-01-23 ms9000001760161937

    学习了,习惯很重要

    0

相关资讯

罗氏公布IMbrave150研究主要终点全新结果:“T+A”方案可显著改善晚期肝癌患者总生存期,中国数据表现尤佳

2021年1月12日,罗氏宣布即将在本月举行的美国临床肿瘤学会胃肠道肿瘤研讨会(ASCO GI)上正式报告IMbrave150研究总生存(overall survival, OS)最新结果。

Eur Radiol:肝癌累及了肝静脉或下腔静脉,经动脉化疗栓塞后总生存率怎么样?

肝癌累及了肝静脉或下腔静脉,经动脉化疗栓塞后总生存率怎么样?

Nat Commun:肠道微生物群影响肝癌外周免疫反应

来自NAFLD-HCC微生物群的细菌提取物,而不是来自对照组的细菌提取物,会引起T细胞免疫抑制表型,其特征是调节性T细胞的扩张和CD8 + T细胞的衰减。

J Hepatol:端粒酶,肝癌的新潜在治疗靶点!

端粒酶激活是肝细胞癌(HCC)发展的最早事件。端粒长度(TL)受TERT(端粒逆转录酶)、TERC(端粒RNA组分)和多种蛋白组成的端粒复合物的调控。本研究旨在阐明肝癌发生过程中的端粒长度的变化及调控

Clin Cancer Res:ST6GAL1,乐伐替尼易感性FGF19驱动的肝癌的新血清生物标志物!

本研究旨在探究可指示对乐伐替尼敏感性的HCC生物标记物。